These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24486738)

  • 1. Iron homeostasis in breast cancer.
    Marques O; da Silva BM; Porto G; Lopes C
    Cancer Lett; 2014 May; 347(1):1-14. PubMed ID: 24486738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis.
    Kabat GC; Rohan TE
    Cancer Causes Control; 2007 Dec; 18(10):1047-53. PubMed ID: 17823849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron homeostasis and anemia markers in early breast cancer.
    Lamy PJ; Durigova A; Jacot W
    Clin Chim Acta; 2014 Jul; 434():34-40. PubMed ID: 24768787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin.
    Chekhun VF; Lukyanova NY; Burlaka CA; Bezdenezhnykh NA; Shpyleva SI; Tryndyak VP; Beland FA; Pogribny IP
    Int J Oncol; 2013 Nov; 43(5):1481-6. PubMed ID: 23969999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iron metabolism in breast cancer: knowledge and future].
    Durigova A; Jacot W; Pouderoux S; Roques S; Montels F; Lamy PJ
    Ann Biol Clin (Paris); 2012; 70(4):387-96. PubMed ID: 22796610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents.
    Pogribny IP; Tryndyak VP; Pogribna M; Shpyleva S; Surratt G; Gamboa da Costa G; Beland FA
    Int J Oncol; 2013 May; 42(5):1822-32. PubMed ID: 23483119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.
    Zghair AN; Sharma R; Sharma AK
    Curr Pharm Biotechnol; 2014; 15(12):1113-24. PubMed ID: 25429655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron: a new target for pharmacological intervention in neurodegenerative diseases.
    Whitnall M; Richardson DR
    Semin Pediatr Neurol; 2006 Sep; 13(3):186-97. PubMed ID: 17101458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages.
    Alkhateeb AA; Han B; Connor JR
    Breast Cancer Res Treat; 2013 Feb; 137(3):733-44. PubMed ID: 23306463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal quercetin intake during pregnancy results in an adapted iron homeostasis at adulthood.
    Vanhees K; Godschalk RW; Sanders A; van Waalwijk van Doorn-Khosrovani SB; van Schooten FJ
    Toxicology; 2011 Dec; 290(2-3):350-8. PubMed ID: 22064046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron metabolism and toxicity.
    Papanikolaou G; Pantopoulos K
    Toxicol Appl Pharmacol; 2005 Jan; 202(2):199-211. PubMed ID: 15629195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of energy metabolism in breast cancer brain metastases.
    Chen EI; Hewel J; Krueger JS; Tiraby C; Weber MR; Kralli A; Becker K; Yates JR; Felding-Habermann B
    Cancer Res; 2007 Feb; 67(4):1472-86. PubMed ID: 17308085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators.
    Amit T; Avramovich-Tirosh Y; Youdim MB; Mandel S
    FASEB J; 2008 May; 22(5):1296-305. PubMed ID: 18048580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal-induced hepatotoxicity.
    Britton RS
    Semin Liver Dis; 1996 Feb; 16(1):3-12. PubMed ID: 8723319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular iron homeostasis and therapeutic implications of iron chelators in cancer.
    Raza M; Chakraborty S; Choudhury M; Ghosh PC; Nag A
    Curr Pharm Biotechnol; 2014; 15(12):1125-40. PubMed ID: 25496094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
    Jiang XP; Wang F; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2002; 22(5):2685-92. PubMed ID: 12529982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lipid-soluble iron chelator alters cell cycle regulatory protein binding in breast cancer cells compared to normal breast cells.
    Pahl PM; Reese SM; Horwitz LD
    J Exp Ther Oncol; 2007; 6(3):193-200. PubMed ID: 17552359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron, oxidative stress and the example of solar ultraviolet A radiation.
    Aroun A; Zhong JL; Tyrrell RM; Pourzand C
    Photochem Photobiol Sci; 2012 Jan; 11(1):118-34. PubMed ID: 21986918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.